Crossmark

Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulant-based triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

Crossref DOI link: https://doi.org/10.1007/s00228-025-03982-9

Published Online: 2026-01-19

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ku, Minhee

Lee, Yu Jeong

Je, Nam Kyung
License Information

Text and Data Mining valid from 2026-01-19

Version of Record valid from 2026-01-19
More Information

Article History

Received: 5 August 2025

Accepted: 10 December 2025

First Online: 19 January 2026

Declarations

:

: Approval of the analyses was obtained with a waiver of informed consent from the Pusan National University IRB Committee [PNU IRB/2024_64_HR].

: Informed consent was waived by the IRB owing to the retrospective nature of the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below